D
Y-mAbs Therapeutics, Inc. YMAB
$7.08 $0.233.36%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Good
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.66
Price History YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 14.01%
30-Day Total Return 31.84%
60-Day Total Return 41.88%
90-Day Total Return 28.73%
Year to Date Total Return 47.19%
1-Year Total Return 62.39%
2-Year Total Return -58.45%
3-Year Total Return -86.06%
5-Year Total Return -68.01%
52-Week High % Change -35.34%
52-Week Low % Change 162.22%
Price YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $10.95
52-Week Low Price $2.70
52-Week Low Price (Date) Mar 24, 2023
52-Week High Price (Date) May 15, 2023
Valuation YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $308.84M
Enterprise Value 223.89M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.45
Earnings Per Share Growth -85.37%
Price/Earnings To Growth --
Price/Sales (TTM) 3.32
Price/Book (Q) 3.08
Enterprise Value/Revenue (TTM) 2.41
Price $7.08
Enterprise Value/EBITDA (TTM) -32.69
Enterprise Value/EBIT -29.26
Market Cap Category Small Cap
Dividends and Shares YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 43.621M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 646 885 8505
Address 230 Park Avenue New York, NY 10169
Website www.ymabs.com
Country United States
Year Founded 2015
Profitability YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -8.23%
Profit Margin -20.75%
Management Effectiveness YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -3.51%
Return on Equity --
Income Statement YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) $92.90M
Total Revenue (TTM) $92.90M
Revenue Per Share $2.13
Gross Profit (TTM) $81.51M
EBITDA (TTM) -$6.85M
EBIT (TTM) -$7.65M
Net Income (TTM) -$19.28M
Net Income Avl. to Common (TTM) -$19.28M
Total Revenue Growth (Q YOY) 63.15%
Earnings Growth (Q YOY) 71.86%
EPS Diluted (TTM) -$0.45
EPS Diluted Growth (Q YOY) 71.43%
Balance Sheet YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $86.57M
Cash Per Share (Q) $1.98
Total Current Assets (Q) $114.86M
Total Preferred Equity (Q) --
Total Equity (Q) $100.15M
Current Ratio (Q) 5.266
Book Value Per Share (Q) $2.30
Total Assets (Q) $128.88M
Total Current Liabilities (Q) $21.81M
Total Debt (Q) $1.62M
Total Liabilities (Q) $28.73M
Total Common Equity (Q) $100.15M
Cash Flow YMAB - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) $0.00
Net Change in Cash (TTM) -$27.96M
Levered Free Cash Flow (TTM) -$8.71M
Cash from Operations (TTM) -$27.86M
Weiss Ratings